FunBioMed - "Novel functionalised biopolymers for medical applications"

Maciej_Guzik.jpg

Maciej Guzik, PhD

Project Leader

Karolina_Stępień.jpg

Karolina Stepien, MSc

Scientist

Daria_Solarz.jpg

Daria Solarz, MSc

Scientist

Szymon_Skibinski.jpg

Szymon Skibinski, MSc, Eng.

Scientist

mariusz_soltysik.jpg

Mariusz Sołtysik, PhD

Scientist with PhD

Tomasz Witko.jpg

Tomasz Witko, PhD

Scientist

Martyna_Podobińska.jpg

Martyna Seta, MSc

Scientist

Katarzyna_Harazna.jpg

Katarzyna Harazna, MSc, Eng

Scientist

Ewelina_Cichoń.jpg

Ewelina Cichon, MSc, Eng.

Scientist

Production of novel functionalised polymers and characterization of their material properties

First part of the FunBioMed project employs production of bacterial polymers in a controlled manner. PHA polymers will be functionalised using a variety of enzymes with different drugs (such as antibiotics, steroids and nonsteroidal anti-inflammatory drugs). Next we will formulate materials for specific applications and describe their physical properties on micro and macro scales.

pha_Lider.jpg

Testing materials for their applications in medicine

The final stage of the project envisages testing of the chosen functionalised PHAs in vivo. We will proceed with an animal model in order to assess the effectiveness of novel biomaterials in wound healing.

pha_Lider3.jpg

Biological properties characterization of novel materials

Once we will establish the production process and describe phiscal properties of the novel materials, we will start biological tests. The novel functionalised materials will be characterized in vitro for their biocompatibility with chosen cell lines appropriate for their future applications. In parallel we will conduct test in order to descibe antibacterial properties of the novel functionalised PHAs.

pha_Lider2.jpg

Acnowlegments

PROJECT LIDER "Novel functionalised biopolymers for medical applications" is sponsored by the Polish National Centre for Research and Developement 

NCBiR+lider.jpg